Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease.
iPS细胞衍生多巴胺能细胞治疗帕金森病的I/II期试验
期刊:Nature
影响因子:48.5
doi:10.1038/s41586-025-08700-0
Sawamoto Nobukatsu, Doi Daisuke, Nakanishi Etsuro, Sawamura Masanori, Kikuchi Takayuki, Yamakado Hodaka, Taruno Yosuke, Shima Atsushi, Fushimi Yasutaka, Okada Tomohisa, Kikuchi Tetsuhiro, Morizane Asuka, Hiramatsu Satoe, Anazawa Takayuki, Shindo Takero, Ueno Kentaro, Morita Satoshi, Arakawa Yoshiki, Nakamoto Yuji, Miyamoto Susumu, Takahashi Ryosuke, Takahashi Jun